Please complete the fields above to begin your download.

According to the CDC's research, Hospital Acquired Infection (HAI) affects one in every 25 patients admitted to hospitals.

While vulnerable populations such as those undergoing organ transplants, immunosuppression, Caesarian sections and joint replacement are most at risk, HAIs are a problem across the entire healthcare industry. 

The direct and indirect costs of treating HAIs and the high mortality rate associated with these infections – in 2011, about 75,000 patients with HAIs died during their hospital stay – demand a tighter focus on their treatment and defense in order to achieve better patient outcomes. 

This paper explores the differences between treating HAIs as they occur and using preventative measures to defend against them.